This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN A. GANTZ, M.D.; JOHN A. NUETZEL, M.D.; LOUIS B. KELLER, M.D.

AMA Arch Intern Med. 1958;102(5):795-800.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Cryptococcosis, in common with many fungal diseases, remains a difficult problem due to the lack of an effective therapeutic agent.^1-4 Reports of new antifungal drugs, notably nystatin and Actidione,^3,5-8 have helped to stimulate interest in this disease. Amphotericin B, a recently isolated derivative of a streptomycete,^9-11 has shown promise in the therapy of several fungal diseases, including cryptococcosis. Reports of clinical trials are few; Appelbaum and Shtokalko ¹² illustrated the arrest of cryptococcal meningitis with Amphotericin B, though evaluation of therapy is difficult in a disease known for spontaneous remissions.^1,2,13-15

The following case of cryptococcal meningitis treated with amphotericin B, but ending fatally in spite of clearing the spinal fluid of organisms, is presented to add to the clinical experience in the use of this drug.

Report of Case

A 32-year-old housewife was first admitted to St. Mary's Hospital on Oct. 8, 1956, for delivery of . . . [Full Text PDF of this Article]

Author Affiliations
St. Louis

From the Department of Internal Medicine, St. Louis University School of Medicine, and the Medical Service of the St. Mary's Group of Hospitals of St. Louis University School of Medicine.

Footnotes
Submitted for publication March 24, 1958.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?